Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

15.2%

7 terminated/withdrawn out of 46 trials

Success Rate

79.4%

-7.1% vs industry average

Late-Stage Pipeline

15%

7 trials in Phase 3/4

Results Transparency

48%

13 of 27 completed trials have results

Key Signals

3 recruiting13 with results

Enrollment Performance

Analytics

N/A
23(53.5%)
Phase 2
6(14.0%)
Phase 1
5(11.6%)
Phase 4
5(11.6%)
Early Phase 1
2(4.7%)
Phase 3
2(4.7%)
43Total
N/A(23)
Phase 2(6)
Phase 1(5)
Phase 4(5)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (46)

Showing 20 of 46 trials
NCT05699642Phase 2Completed

Online Tai Chi Plus Fitbit After ACS

Role: collaborator

NCT07699484Early Phase 1Not Yet Recruiting

Digital Intervention Delivered Via Street Medicine to Increase HIV and Substance Use Care Among Survivors of Sex Trafficking

Role: lead

NCT05512143Not ApplicableCompleted

TMS for PTSD and Blood Pressure

Role: lead

NCT05184556Not ApplicableCompleted

Project HOME: Home-Based Treatment Options and Mechanisms for Eating Disorders

Role: collaborator

NCT06880718Phase 4Recruiting

Injectable Buprenorphine in Prison: A Preference Trial

Role: lead

NCT05599620Not ApplicableCompleted

Reducing Alcohol Use and Sexual Dysfunction in Survivors of Sexual Trauma

Role: lead

NCT05839119Phase 1Terminated

Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant

Role: collaborator

NCT03589547Phase 2Completed

Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung

Role: collaborator

NCT06805799Not ApplicableNot Yet Recruiting

Stress Reactivity and Mother-Infant Cardiovascular Disease Risk

Role: lead

NCT06953479Phase 4Recruiting

Implementing Low-Barrier HCV Treatment in a Jail Setting

Role: lead

NCT04626245Not ApplicableActive Not Recruiting

Mindfulness & Mechanisms Study

Role: lead

NCT03850912Not ApplicableCompleted

Symptom Management Implementation of Patient Reported Outcomes in Oncology

Role: collaborator

NCT02353312Not ApplicableCompleted

Rhode Island Diastolic Dysfunction - Heart Failure

Role: collaborator

NCT03789591Phase 3Completed

Hydroxyurea Optimization Through Precision Study

Role: lead

NCT05646446Not ApplicableWithdrawn

Integrated Alcohol and Sexual Assault Prevention for Bisexual Women

Role: lead

NCT05110313Phase 4Completed

Effects of Tildrakizumab on Epigenetic Age

Role: collaborator

NCT06354465Recruiting

Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: Qualitative Interviews

Role: lead

NCT04598321Phase 1Terminated

BrUOG 390: Neoadjuvant Treatment With Talazoparib

Role: collaborator

NCT03679117Not ApplicableCompleted

Prenatal Mindfulness & Hypertension Study

Role: lead

NCT05773027Not ApplicableCompleted

Integrated Alcohol and Sexual Assault Intervention for College Men

Role: lead